Literature DB >> 7224599

Catecholamine-associated refractory hypertension following acute intracranial hemorrhage: control with propranolol.

J H Feibel, C A Baldwin, R J Joynt.   

Abstract

Seven patients (4 with subarachnoid hemorrhage, 2 with intracerebral hemorrhage, and 1 with massive cerebral infarction) had acute arterial hypertension refractory to control by several antihypertensive drugs (hydralazine, sodium nitroprusside, alpha-methyldopa, and trimethaphan camsylate) used singly or in combination. In each case, catecholamine excretion--measured by urinary norepinephrine plus epinephrine--was markedly elevated, averaging 218 microgram/day. Patients without the acute refractory hypertension had normal or only slightly elevated urinary catecholamine levels (mean, 72 microgram/day). The beta-adrenergic blocking agent propranolol, in doses between 20 and 40 mg every 6 hours, successfully controlled blood pressure, while other agents failed. The intense sympathetic nervous system discharge resulting in acute refractory hypertension may be due to injury to the diencephalon or brainstem (or both) or to diffuse brain dysfunction from increased intracranial pressure or intracranial blood.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7224599     DOI: 10.1002/ana.410090405

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  7 in total

Review 1.  Autonomic dysfunction syndromes after acute brain injury.

Authors:  Courtney Takahashi; Holly E Hinson; Ian J Baguley
Journal:  Handb Clin Neurol       Date:  2015

Review 2.  A critical review of the pathophysiology of dysautonomia following traumatic brain injury.

Authors:  Ian J Baguley; Roxana E Heriseanu; Ian D Cameron; Melissa T Nott; Shameran Slewa-Younan
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

3.  Treatment of paroxysmal sympathetic hyperactivity.

Authors:  Alejandro A Rabinstein; Eduardo E Benarroch
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

4.  β-blockers in critically ill patients: from physiology to clinical evidence.

Authors:  Silvia Coppola; Sara Froio; Davide Chiumello
Journal:  Crit Care       Date:  2015-03-16       Impact factor: 9.097

5.  Beta-adrenergic blockade for attenuation of catecholamine surge after traumatic brain injury: a randomized pilot trial.

Authors:  Thomas J Schroeppel; John P Sharpe; Charles Patrick Shahan; Lesley P Clement; Louis J Magnotti; Marilyn Lee; Michael Muhlbauer; Jordan A Weinberg; Elizabeth A Tolley; Martin A Croce; Timothy C Fabian
Journal:  Trauma Surg Acute Care Open       Date:  2019-08-18

6.  Which Parameters of Beat-to-Beat Blood Pressure Best Predict Poor In-Hospital Outcome in Spontaneous Intracerebral Hemorrhage?

Authors:  Zhen-Ni Guo; Yang Qu; Hailili Reziya; Jia Liu; Xiu-Li Yan; Peng Zhang; Pan-Deng Zhang; Shuang Qi; Yi Yang
Journal:  Front Aging Neurosci       Date:  2020-11-19       Impact factor: 5.750

Review 7.  Paroxysmal Sympathetic Hyperactivity in Moderate-to-Severe Traumatic Brain Injury and the Role of Beta-Blockers: A Scoping Review.

Authors:  Stéphane Nguembu; Marco Meloni; Geneviève Endalle; Hugues Dokponou; Olaoluwa Ezekiel Dada; Wah Praise Senyuy; Ulrick Sidney Kanmounye
Journal:  Emerg Med Int       Date:  2021-09-11       Impact factor: 1.112

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.